Evidence map›Paper›PMID 31399940›Full record

ArticleJournal of the American Society for Mass Spectrometry2019

Chemoselectivity in the Oxidation of Cycloalkenes with a Non-Heme Iron(IV)-Oxo-Chloride Complex: Epoxidation vs. Hydroxylation Selectivity.

Thibault Terencio, Erik Andris, Ilaria Gamba, Martin Srnec, Miquel Costas, Jana Roithová

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. The [(Bn-tpen)FeMolecules (Basel, Switzerland) · 2024
    Article
  2. A tale of two topological isomers: Uptuning [FeProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  3. Article
  4. Unmasking the Iron-Oxo Bond of the [(Ligand)Fe-OIAr]Journal of the American Society for Mass Spectrometry · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Thibault TerencioDepartment of Organic Chemistry, Faculty of Science, Charles University, Hlavova 2030/8, 128 43, Prague 2, Czech Republic.
Erik AndrisDepartment of Organic Chemistry, Faculty of Science, Charles University, Hlavova 2030/8, 128 43, Prague 2, Czech Republic.
Ilaria GambaDepartament de Quimica and Institute of Computational Chemistry and Catalysis (IQCC), University of Girona, Campus Montilivi, 17071, Girona, Spain.
Martin SrnecJ. Heyrovsky Institute of Physical Chemistry of the CAS, v. v. i., Dolejškova 2155/3, 182 23, Prague 8, Czech Republic. martin.srnec@jh-inst.cas.cz.
Miquel CostasDepartament de Quimica and Institute of Computational Chemistry and Catalysis (IQCC), University of Girona, Campus Montilivi, 17071, Girona, Spain. miquel.costas@udg.edu.
Jana RoithováDepartment of Organic Chemistry, Faculty of Science, Charles University, Hlavova 2030/8, 128 43, Prague 2, Czech Republic. jana.roithova@ru.nl.ORCID http://orcid.org/0000-0001-5144-0688
Charles University · CZUniversity of Girona · ESCzech Academy of Sciences, J. Heyrovský Institute of Physical Chemistry · CZUniversidad Yachay Tech · EC

Funding

European Research Council 682275Grantová Agentura České Republiky 18-13093S
6 · The paper itself

Abstract

We report and analyze chemoselectivity in the gas phase reactions of cycloalkenes (cyclohexene, cycloheptene, cis-cyclooctene, 1,4-cyclohexadiene) with a non-heme iron(IV)-oxo complex [(PyTACN)Fe(O)(Cl)]

Indexed as

C–H activationDFT calculationsEpoxidationGas-phase reactionsIron complexes

Identifiers

PMID31399940
PMCPMC6805805
OpenAlexW2967882802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.